HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.

Abstract
Both increased estrogen receptor alpha (ER(alpha)) expression and germline disruption of one p53 allele increase breast cancer risk in women. Genetically engineered mouse models of deregulated ER(alpha) expression and p53 haploinsufficiency were used to investigate similarities and differences of each genetic lesion alone and in combination on mammary preneoplasia development. Each genetic lesion independently and in combination led to development of age-dependent preneoplasia, but the highest prevalence was found in compound mice with increased ER(alpha) expression coupled with p53 heterozygosity. All genetic lesions were associated with extracellular signal-regulated kinase 1/2 activation; however, only p53 heterozygous and compound mice showed increased levels of phosphorylated AKT and decreased p27 expression. The highest levels of cell proliferation were found in compound mice, but increased levels were also found with either increased ER(alpha) expression or p53 heterozygosity. Mice with increased ER(alpha) expression showed predicted higher levels of nuclear-localized ER(alpha), but this was attenuated in compound mice in association with a relative increase in Src phosphorylation. Parity protection was limited to p53 heterozygous mice and not found in mice with increased ER(alpha) alone. In summary, increased and deregulated ER(alpha) collaborates with p53 heterozygosity in increasing the risk of mammary preneoplasia development.
AuthorsEdgar S Díaz-Cruz, Priscilla A Furth
JournalCancer research (Cancer Res) Vol. 70 Issue 10 Pg. 3965-74 (May 15 2010) ISSN: 1538-7445 [Electronic] United States
PMID20466998 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright(c)2010 AACR.
Chemical References
  • Estrogen Receptor alpha
  • RNA, Messenger
  • Tumor Suppressor Protein p53
Topics
  • Animals
  • Animals, Newborn
  • Apoptosis
  • Blotting, Western
  • Cell Proliferation
  • Estrogen Receptor alpha (metabolism)
  • Female
  • Heterozygote
  • Immunoenzyme Techniques
  • Mammary Glands, Animal (metabolism, pathology)
  • Mammary Neoplasms, Animal (genetics, metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Parity
  • Precancerous Conditions (genetics, metabolism, pathology)
  • Pregnancy
  • RNA, Messenger (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: